Eplerenone vs. spironolactone in heart failure: long-term cardiorenal and mortality outcomes in a registry-based cohort

Karl Wärnberg, Carl Haggård, Karin Bergen, Henrik Falhammar, Buster Mannheimer, Krister Lindmark

Open source

DOI: 10.1093/ehjcvp/pvag064
Published: 2026-09-10
Container: European Heart Journal - Cardiovascular Pharmacotherapy
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ehjcvp/pvag064,
  title = {Eplerenone vs. spironolactone in heart failure: long-term cardiorenal and mortality outcomes in a registry-based cohort},
  author = {Karl Wärnberg and Carl Haggård and Karin Bergen and Henrik Falhammar and Buster Mannheimer and Krister Lindmark},
  year = {2026},
  journal = {European Heart Journal - Cardiovascular Pharmacotherapy},
  doi = {10.1093/ehjcvp/pvag064},
  url = {https://doi.org/10.1093/ehjcvp/pvag064}
}

RIS

TY  - JOUR
TI  - Eplerenone vs. spironolactone in heart failure: long-term cardiorenal and mortality outcomes in a registry-based cohort
AU  - Karl Wärnberg
AU  - Carl Haggård
AU  - Karin Bergen
AU  - Henrik Falhammar
AU  - Buster Mannheimer
AU  - Krister Lindmark
PY  - 2026
JO  - European Heart Journal - Cardiovascular Pharmacotherapy
DO  - 10.1093/ehjcvp/pvag064
UR  - https://doi.org/10.1093/ehjcvp/pvag064
ER  -

APA

Wärnberg, K., Haggård, C., Bergen, K., Falhammar, H., Mannheimer, B., & Lindmark, K. (2026). Eplerenone vs. spironolactone in heart failure: long-term cardiorenal and mortality outcomes in a registry-based cohort. European Heart Journal - Cardiovascular Pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvag064

Source records

crossref · retrieved 2026-09-26T01:25:22.987Z